Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Industry Broadens Its Approach To Expanded Access

Jan 23 2020

• By Brenda Sandburg

Medical advice and medication guidance and prescription drugs health consultation as a giant pill shaped as a lighthouse beacon with 3D illustration elements. — Expanded access to investigational drugs involves reimbursement and supply hurdles

Related Content

Expanded Access Program Improving, But Sponsor Concerns Linger

Sep 11 2019

Platform Trials Could Be A Solution To Expanded Access, Woodcock Says

Jan 23 2019

J&J's Compassionate Use Advisory Cmte. May Become Industry Model

May 09 2016

FDA Crisis Management: Behind-The-Scenes Of Josh Hardy's Compassionate Use

Oct 29 2015

Related Companies

Novartis AG

Johnson & Johnson

CSL Limited

Chimerix, Inc.

Biohaven Pharmaceutical Holding Company Ltd.

Implicit Bioscience Limited

Sanofi

Merck & Co., Inc.

AstraZeneca PLC

AbbVie Inc.

Roche Holding AG

GSK plc

Additional Topics

United States Real-World Evidence Clinical Trials Reimbursement FDA Policy BioPharmaceutical

More from Real-World Evidence

More from Clinical Trials

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window